Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Fox

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
Pediatric Neurology|May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromasDusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Neuro-Oncology|August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group reportJack M Su, Lindsay B Kilburn, David B Mansur, et al.
Plos One|June 15, 2010
Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogsMelissa C Paoloni, Christina Mazcko, Elizabeth Fox, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Neurocritical Care|May 18, 2023
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid HemorrhageMiriam M Treggiari, Alejandro A Rabinstein, Katharina M Busl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescentsMaya Lodish, Urania Dagalakis, Clara C Chen, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Pediatric Neurology|May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromasDusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Neuro-Oncology|August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group reportJack M Su, Lindsay B Kilburn, David B Mansur, et al.
Plos One|June 15, 2010
Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogsMelissa C Paoloni, Christina Mazcko, Elizabeth Fox, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Neurocritical Care|May 18, 2023
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid HemorrhageMiriam M Treggiari, Alejandro A Rabinstein, Katharina M Busl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescentsMaya Lodish, Urania Dagalakis, Clara C Chen, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pageof 19